About: Computational Prediction of the Comprehensive SARS-CoV-2 vs. Human Interactome to Guide the Design of Therapeutics

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Computational Prediction of the Comprehensive SARS-CoV-2 vs. Human Interactome to Guide the Design of Therapeutics Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Computational Prediction of the Comprehensive SARS-CoV-2 vs. Human Interactome to Guide the Design of Therapeutics
Creator	Biggar, Kyle Dick, Kevin Green, James
Source	BioRxiv
abstract	Understanding the disease pathogenesis of the novel coronavirus, denoted SARS-CoV-2, is critical to the development of anti-SARS-CoV-2 therapeutics. The global propagation of the viral disease, denoted COVID-19 (“coronavirus disease 2019”), has unified the scientific community in searching for possible inhibitory small molecules or polypeptides. Given the known interaction between the human ACE2 (“Angiotensin-converting enzyme 2”) protein and the SARS-CoV virus (responsible for the coronavirus outbreak circa. 2003), considerable focus has been directed towards the putative interaction between the SARS-CoV-2 Spike protein and ACE2. However, a more holistic understanding of the SARS-CoV-2 vs. human inter-species interactome promises additional putative protein-protein interactions (PPI) that may be considered targets for the development of inhibitory therapeutics. To that end, we leverage two state-of-the-art, sequence-based PPI predictors (PIPE4 & SPRINT) capable of generating the comprehensive SARS-CoV-2 vs. human interactome, comprising approximately 285,000 pairwise predictions. Of these, we identify the high-scoring subset of human proteins predicted to interact with each of the 14 SARS-CoV-2 proteins by both methods, comprising 279 high-confidence putative interactions involving 225 human proteins. Notably, the Spike-ACE2 interaction was the highest ranked for both the PIPE4 and SPRINT predictors, corroborating existing evidence for this PPI. Furthermore, the PIPE-Sites algorithm was used to predict the putative subsequence that might mediate each interaction and thereby inform the design of inhibitory polypeptides intended to disrupt the corresponding host-pathogen interactions. We hereby publicly release the comprehensive set of PPI predictions and their corresponding PIPE-Sites landscapes in the following DataVerse repository: 10.5683/SP2/JZ77XA. All data and metadata are released under a CC-BY 4.0 licence. The information provided represents theoretical modeling only and caution should be exercised in its use. It is intended as a resource for the scientific community at large in furthering our understanding of SARS-CoV-2.
has issue date	2020-03-31(xsd:dateTime)
bibo:doi	10.1101/2020.03.29.014381
has license	biorxiv
sha1sum (hex)	e0b8d74fe9e347bed6d9e655335c33e2354ab467
schema:url	https://doi.org/10.1101/2020.03.29.014381
resource representing a document's title	Computational Prediction of the Comprehensive SARS-CoV-2 vs. Human Interactome to Guide the Design of Therapeutics
schema:publication	bioRxiv
resource representing a document's body	covid:e0b8d74fe9e347bed6d9e655335c33e2354ab467#body_text
is schema:about of	named entity 'protein' named entity 'development' named entity 'coronavirus disease 2019' named entity 'protein' named entity 'PPI' named entity 'SARS-CoV' named entity 'protein' named entity 'coronavirus outbreak' named entity 'Angiotensin-converting enzyme 2' named entity 'holistic' named entity 'interactome' named entity 'SARS-CoV-2' named entity 'pathogenesis' named entity 'SARS-COV-2' named entity 'research community' named entity 'SARS-CoV-2' named entity 'protein' named entity 'holistic' named entity 'ACE2' named entity 'Coronaviridae' named entity 'Zika Virus' named entity 'peptide sequence' named entity 'Gene Ontology' named entity 'gene expression' named entity 'viruses' named entity 'Dengue virus' named entity 'PPIs' named entity 'virus' named entity 'protein structure' named entity 'Protein' named entity 'glutamine synthetase' named entity 'viruses' named entity 'Figure 8' named entity 'Zika' named entity 'high-performance computing' named entity 'PPI' named entity 'Gene Ontology' named entity 'yeast-two hybrid' named entity 'wet laboratory' named entity 'peptide-based' named entity 'supercomputer' named entity 'Coronaviruses' named entity 'ACE2 receptor' named entity 'PPI' named entity 'time complexity' named entity 'SARS-CoV-2' named entity 'biological pathway' named entity 'viral proteins' named entity 'protein complex' named entity 'PPIs' named entity 'interactome' named entity 'Gene Ontology' named entity 'PPI' named entity 'viruses' named entity 'Uniprot' named entity 'FDR' named entity 'high-throughput' named entity 'SARS-CoV-2' named entity 'SARS-CoV' named entity 'protein' named entity 'HLA' named entity 'SARS-CoV-2' named entity 'Gene Ontology' named entity 'interactome' named entity 'virus' named entity 'PPI' named entity 'human reference' named entity 'ACE2' named entity 'pathogenesis' named entity 'peptide sequences' named entity '3/3' named entity 'Protein' named entity 'PANTHER' named entity 'virus infection' named entity 'protein-protein interaction' named entity 'SARS-CoV' named entity 'HLA' named entity 'synthetic biology' named entity 'inter-species' named entity 'Uniprot' named entity 'CC-BY 4.0' named entity 'Gene Ontology'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software